dGTP

CAS No. 2564-35-4

dGTP( 2'-deoxyguanosine 5'-(tetrahydrogen triphosphate) )

Catalog No. M28283 CAS No. 2564-35-4

dGTP is one of the guanosine nucleotides which is highly susceptible to oxidative damage to 8-O-GDP, 8-O-dGTP, 8-O-GTP, and 8-O-dGTP.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG 1368 Get Quote
500MG 2673 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    dGTP
  • Note
    Research use only, not for human use.
  • Brief Description
    dGTP is one of the guanosine nucleotides which is highly susceptible to oxidative damage to 8-O-GDP, 8-O-dGTP, 8-O-GTP, and 8-O-dGTP.
  • Description
    dGTP is one of the guanosine nucleotides which is highly susceptible to oxidative damage to 8-O-GDP, 8-O-dGTP, 8-O-GTP, and 8-O-dGTP.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2'-deoxyguanosine 5'-(tetrahydrogen triphosphate)
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Nucleoside Antimetabolite/Analog
  • Recptor
    Antibacterial|L. donovani
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2564-35-4
  • Formula Weight
    507.18
  • Molecular Formula
    C10H16N5O13P3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@@H](C[C@H](N1C=NC2=C1N=C(N)NC2=O)O3)[C@H]3COP(O)(OP(OP(O)(O)=O)(O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Keurulainen L, et al. Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae. J Med Chem. 2010 Nov 11;53(21):7664-74.
molnova catalog
related products
  • Isoguanine

    Isoguanine is a purine base that is an isomer of guanine. A building block in organic synthesis.

  • GS-441524

    GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at least 12 weeks.

  • Raltitrexed

    A quinazoline antifolate thymidylate synthase (TS) inhibitor with Ki of 62 nM.